Skip to main content
. 2021 Apr 5;11(4):e367. doi: 10.1002/ctm2.367

FIGURE 4.

FIGURE 4

LncRNAs are used as a diagnostic tool for early lung cancer screening. Because LDCT has a high false positive rate, lncRNAs can be act as an auxiliary detection tool to diagnose diseases. LncRNAs are stable in the blood. After LDCT screening, patients were drawn blood to extract RNAs. Identifying the expression levels of different lncRNAs in the patient's blood by PCR, which can distinguish between lung cancer and benign lung disease